Page 15 - Read Online

Page 10 of 11 Cox et al. J Cancer Metastasis Treat 2021;7:25 https://dx.doi.org/10.20517/2394-4722.2021.55

17. Ong SC, Schöder H, Lee NY, et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for
Locoregional advanced head and neck cancer. J Nucl Med 2008;49:532-40. DOI PubMed
18. Schöder H, Fury M, Lee N, Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med
2009;50 Suppl 1:74S-88S. DOI PubMed
19. Helsen N, Van den Wyngaert T, Carp L, Stroobants S. FDG-PET/CT for treatment response assessment in head and neck squamous
cell carcinoma: a systematic review and meta-analysis of diagnostic performance. Eur J Nucl Med Mol Imaging 2018;45:1063-71.
DOI PubMed
20. Van den Wyngaert T, Helsen N, Carp L, et al. Fluorodeoxyglucose-positron emission tomography/computed tomography after
concurrent chemoradiotherapy in locally advanced head-and-neck squamous cell cancer: The ECLYPS Study. J Clin Oncol
2017;35:3458-64. DOI PubMed
21. Bussink J, van Herpen CM, Kaanders JH, Oyen WJ. PET-CT for response assessment and treatment adaptation in head and neck
cancer. Lancet Oncol 2010;11:661-9. DOI PubMed
22. Mehanna H, Wong WL, McConkey CC, et al. PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J
Med 2016;374:1444-54. DOI PubMed
23. Dornfeld K, Hopkins S, Simmons J, et al. Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with
decreased quality of life after chemoradiotherapy. Int J Radiat Oncol Biol Phys 2008;71:386-92. DOI PubMed PMC
18
24. Delouya G, Igidbashian L, Houle A, et al. F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and
neck cancer. Radiother Oncol 2011;101:362-8. DOI PubMed
25. Guido A, Fuccio L, Rombi B, et al. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Int J Radiat Oncol Biol Phys 2009;73:759-63. DOI PubMed
26. Koshy M, Paulino AC, Howell R, Schuster D, Halkar R, Davis LW. F-18 FDG PET-CT fusion in radiotherapy treatment planning for
head and neck cancer. Head Neck 2005;27:494-502. DOI PubMed
27. Mazzola R, Alongi P, Ricchetti F, et al. 18F-Fluorodeoxyglucose-PET/CT in locally advanced head and neck cancer can influence the
stage migration and nodal radiation treatment volumes. Radiol Med 2017;122:952-9. DOI PubMed
18
28. van den Bosch S, Doornaert PAH, Dijkema T, et al. F-FDG-PET/CT-based treatment planning for definitive (chemo)radiotherapy in
patients with head and neck squamous cell carcinoma improves regional control and survival. Radiother Oncol 2020;142:107-14. DOI
PubMed
29. van den Bosch S, Vogel WV, Raaijmakers CP, et al. Implications of improved diagnostic imaging of small nodal metastases in head
and neck cancer: radiotherapy target volume transformation and dose de-escalation. Radiother Oncol 2018;128:472-8. DOI PubMed
30. den Bosch S, Dijkema T, Verhoef LC, Zwijnenburg EM, Janssens GO, Kaanders JH. Patterns of recurrence in electively irradiated
lymph node regions after definitive accelerated intensity modulated radiation therapy for head and neck squamous cell carcinoma. Int J
Radiat Oncol Biol Phys 2016;94:766-74. DOI PubMed
31. van den Bosch S, Dijkema T, Philippens MEP, et al. Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the
18
reproducibility of F-FDG-PET based tumor segmentation in head and neck squamous cell carcinoma in a multicenter setting.
Radiother Oncol 2019;130:39-45. DOI PubMed
32. van den Bosch S, Dijkema T, Kunze-Busch MC, et al. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late
Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and
neck squamous cell carcinoma. BMC Cancer 2017;17:208. DOI PubMed PMC
33. Withers H, Peters LJ, Taylor JM. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys
1995;31:353-9. DOI PubMed
34. Kaanders JHAM, van den Bosch S, Dijkema T, Al-Mamgani A, Raaijmakers CPJ, Vogel WV. Advances in cancer imaging require
renewed radiotherapy dose and target volume concepts. Radiother Oncol 2020;148:140-2. DOI PubMed
35. Deschuymer S, Nevens D, Duprez F, et al. Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and
neck squamous cell carcinoma; update of the long-term tumor outcome. Radiother Oncol 2020;143:24-9. DOI PubMed
36. Sher DJ, Pham NL, Shah JL, et al. Prospective phase 2 study of radiation therapy dose and volume de-escalation for elective neck
treatment of oropharyngeal and laryngeal cancer. Int J Radiat Oncol Biol Phys 2021;109:932-40. DOI PubMed
37. Deschuymer S, Nevens D, Duprez F, et al. Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and
neck squamous cell carcinoma: results on the quality of life. Qual Life Res 2021;30:117-27. DOI PubMed
38. Nevens D, Duprez F, Daisne JF, et al. Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell
carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control. Radiother Oncol 2017;122:171-7. DOI PubMed
39. Maguire PD, Neal CR, Hardy SM, Schreiber AM. Single-arm phase 2 trial of elective nodal dose reduction for patients with
locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2018;100:1210-6. DOI
PubMed PMC
40. Tsai CJ, McBride SM, Riaz N, Lee NY. Reducing the radiation therapy dose prescription for elective treatment areas in human
papillomavirus-associated oropharyngeal carcinoma being treated with primary chemoradiotherapy at memorial sloan kettering cancer
center. Pract Radiat Oncol 2019;9:98-101. DOI PubMed
41. Driessen DAJJ, Dijkema T, Weijs WLJ, et al. Novel diagnostic approaches for assessment of the clinically negative neck in head and
neck cancer patients. Front Oncol 2020;10:637513. DOI PubMed PMC
42. Chow LQM. Head and neck cancer. N Engl J Med 2020;382:60-72. DOI PubMed
43. Pollom EL, Song J, Durkee BY, et al. Prognostic value of midtreatment FDG-PET in oropharyngeal cancer. Head Neck 2016;38:1472-
8. DOI PubMed